Anthem Biosciences Limited (BOM:544449)
India · Delayed Price · Currency is INR 831.85
-6.50 (-0.78%)
At close: Oct 28, 2026
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 468.66 billion as of October 28, 2026. Its market cap has increased by 14.14% in one year.
Market Cap
468.66B
Enterprise Value
459.82B
Revenue
20.07B
Global Rank
n/a
Country Rank
n/a
PE Ratio
82.30
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 468.66B, an increase of 14.26%. That is a compound annual growth rate of 11.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 468.66B | 28.09% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 548.65B |
| Anthem Biosciences | 469.25B |
| OneSource Specialty Pharma | 187.24B |
| Concord Biotech | 136.94B |
| Blue Jet Healthcare | 95.06B |
| Supriya Lifescience | 68.89B |
| Zota Health Care | 45.18B |
| Dishman Carbogen Amcis | 23.36B |